ATAD3A: A Key Regulator of Mitochondria-Associated Diseases
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241512511 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Liting Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Pharmaceutical Sciences, Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern Califor…. Hauptthemen laut MEDLINE: ATPases Associated with Diverse Cellular Activities, Mitochondrial Proteins, Mitochondria, Membrane Proteins. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, John Stauffer Dean’s Chair in Pharmaceutical Sciences at USC.
Abstract (Originalsprache)
Mitochondrial membrane protein ATAD3A is a member of the AAA-domain-containing ATPases superfamily. It is important for the maintenance of mitochondrial DNA, structure, and function. In recent years, an increasing number of ATAD3A mutations have been identified in patients with neurological symptoms. Many of these mutations disrupt mitochondrial structure, function, and dynamics and are lethal to patients at a young age. Here, we summarize the current understanding of the relationship between ATAD3A and mitochondria, including the interaction of ATAD3A with mitochondrial DNA and mitochondrial/ER proteins, the regulation of ATAD3A in cholesterol mitochondrial trafficking, and the effect of known ATAD3A mutations on mitochondrial function. In the current review, we revealed that the oligomerization and interaction of ATAD3A with other mitochondrial/ER proteins are vital for its various functions. Despite affecting different domains of the protein, nearly all documented mutations observed in ATAD3A exhibit either loss-of-function or dominant-negative effects, potentially leading to disruption in the dimerization of ATAD3A; autophagy; mitophagy; alteration in mitochondrial number, size, and cristae morphology; and diminished activity of mitochondrial respiratory chain complexes I, IV, and V. These findings imply that ATAD3A plays a critical role in mitochondrial dynamics, which can be readily perturbed by ATAD3A mutation variants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Pharmaceutical Sciences, Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA 99089, USA.
ORCID-Profile: Vassilios Papadopoulos
Förderung
- USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences
- University of Southern California
- John Stauffer Dean’s Chair in Pharmaceutical Sciences at USC
Zitieren
APA
Chen, L., Li, Y., Zambidis, A., & Papadopoulos, V. (2023). ATAD3A: A Key Regulator of Mitochondria-Associated Diseases. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241512511
Vancouver
Chen L, Li Y, Zambidis A, Papadopoulos V. ATAD3A: A Key Regulator of Mitochondria-Associated Diseases. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241512511
BibTeX
@article{Chen2023,
author = {Chen, Liting and Li, Yuchang and Zambidis, Alexander and Papadopoulos, Vassilios},
title = {ATAD3A: A Key Regulator of Mitochondria-Associated Diseases},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241512511}
}
EUVIMED